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Natural killer (NK) cells play a major role in the initial control of many viral pathogens and in 
the rejection of tumors. Consistent with their roles as immune sentinels, NK cells are found in 
inflamed skin, including lichen planus, psoriasis and atopic dermatitis (AD) lesions. In oral li-
chen planus lesions, the recruitment as well as intradermal colocalization of NK cells and pDC 
(plasmacytoid dendritic cells) appear to be mediated by chemerin, a recently identified protein li-
gand for chemokine-like receptor 1 (CMKLR1), a chemoattractant receptor expressed by both cell 
types. Dendritic cells can regulate NK cell activity, and NK cells can regulate DC-mediated re-
sponses. Since chemerin was recently implicated in recruitment of pDC to psoriatic skin, in this 
work we determined whether chemerin facilitates interactions between NK and pDC in psoriatic 
plaques through controlling influx of NK cells to diseased skin. We demonstrate that circulating 
NK cells from normal donors as well as psoriasis and AD patients respond similarly in function-
al migration assays to chemerin. However, differences in the distribution of NK cells and pDC 
in skin lesions suggest that recruitment of both NK cells and pDC is unlikely to be controlled 
solely by chemerin.
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INTRODUCTION
Chemerin was initially named tazarotene-in-
duced gene 2 (tig-2), a designation that reflects its 
transcriptional upregulation in lesional psoriatic 
skin by the anti-psoriatic synthetic retinoid tazaro-
tene (Nagpal et al., 1997). More recently, through 
G protein-associated receptor screening assays, 
chemerin was identified as a protein ligand for the 
orphan seven-pass transmembrane receptor chemo-
kine-like receptor 1 (CMKLR1) (Wittamer et al., 2003; 
Zabel et al., 2005b). Several specific functions have 
been ascribed to chemerin so far, including regula-
tion of specific immune cell migration (Wittamer et 
al., 2003; Zabel et al., 2005b), anti-inflammatory ef-
fects on macrophages (Cash et al., 2008), and regula-
tion of adipogenesis (Goralski et al., 2007). Human 
chemerin is synthesized as an aprox. 18 kDa precur-
sor which undergoes protease-mediated C-terminal 
truncation to generate a potent chemoattractant for 
CMKLR1-expressing cells. Enzymes that contribute 
to this conversion include host serine proteases of 
the coagulation, fibrinolytic and inflammatory cas-
cades (Du et al., 2009; Wittamer et al., 2005; Zabel et 
al., 2005a), circulating carboxypeptidases (Du et al., 
2009), as well as staphopain B, a cysteine protease 
secreted by Staphylococcus aureus (Kulig et al., 2007). 
CMKLR1 exhibits a selective expression pat-
tern among immune cells. The best documented is 
the presence of this receptor on immature plasmacy-
toid dendritic cells (pDC) and resident macrophages 
(Zabel et al., 2006a; Zabel et al., 2005b). In addition, 
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recent data indicate that a subset of natural killer 
(NK) cells express functional CMKLR1 (Parolini et al., 
2007). NK cells represent an important component 
of the immune system through their ability to both 
lyse target cells and to secrete a variety of immuno-
regulatory cytokines. Although NK cells are mainly 
recognized as cells of the innate immune system ca-
pable of killing virally-infected cells or tumor cells 
(Moretta et al., 2008), recent data indicate that NK 
cells also posses adaptive immune features (Cooper 
et al., 2009; Sun et al., 2009). Interaction between NK 
cells and dendritic cells (DC) is of particular inter-
est, due to mutual modulation of cell function. For 
example, NK cells play an important role in control-
ling DC differentiation or in killing immature DC 
(Moretta et al., 2008). On the other hand, interferon 
alpha-producing pDC induce NK cytolytic activity 
(Colonna et al., 2004). The molecules responsible for 
“bringing these cells together” at sites of inflamma-
tion remain poorly defined. In this context it is of 
interest that NK cells have been shown to colocalize 
with pDC in oral lichen planus lesions in a chemer-
in-dependent manner (Parolini et al., 2007). Chemer-
in-mediated recruitment of pDC and NK cells might 
therefore represent a general mechanism to enable 
pDC and NK cell cross-regulation in diseased skin. 
Recently, we and others have demonstrated 
that chemerin is present in psoriatic skin lesions, and 
likely plays a key role in regulating skin infiltration 
by pDC in psoriasis (Albanesi et al., 2009; Skrzeczyn-
ska-Moncznik et al., 2009). Although pDC are absent 
in normal skin, lesional skin from patients suffering 
from psoriasis vulgaris is characterized by substan-
tial numbers of pDC. Infiltrating NK cells have also 
been described in psoriatic skin, although accumu-
lation of NK cells was reported to be mediated by 
CXCL10, a ligand for CXCR3, and CCL5, a ligand 
for CCR5 (Ottaviani et al., 2006). 
In this work we demonstrate that circulat-
ing NK cell subsets derived from psoriatic patients 
migrate to chemerin, suggesting that this chemoat-
tractant contributes to NK cell migration to diseased 
skin. However, since NK cell infiltration does not al-
ways correlate with the presence of pDC in diseased 
skin, other chemoattractants may provide additive 
or alternative signals in recruiting these cells to af-
fected skin. 
MATERIALS AND METHODS
Chemoattractants. Recombinant human 
CXCL12 (SDF-1α) and recombinant human CXCL10 
(IP-10) were purchased from R&D Systems. Sta-
phopainB (SspB) activated chemerin was prepared 
as described previously (Kulig et al., 2007). Briefly, 
recombinant human pro-chemerin, expressed in in-
sect cells was treated with S. aureus-derived cysteine 
protease SspB at a 100 : 1 pro-chemerin : active SspB 
molar ratio at 37°C in a buffer containing 50 mM 
Hepes, 100 mM NaCl, pH 7.2. The 16 155.4 Da SspB-
mediated cleavage product, further referred to as 
chemerin/SspB was purified by HPLC and used for 
cell migration experiments. Since SspB treatment of 
pro-chemerin generates a potent chemoattractant 
(Kulig et al., 2007), chemerin/SspB was used in all 
experiments as a bioactive form of this molecule. 
Patients. All human studies were performed 
in accordance with guidelines established by the Ja-
giellonian University Institutional Bioethics Commit-
tee under approved protocols. Declaration of Hel-
sinki protocols were followed. A total of 16 psoriasis 
patients (age 36.7 ± 15.1 years; F: 7, M: 9), 14 AD pa-
tients (age 28.9 ± 6.9 years; F: 6, M: 8) and 12 healthy 
individuals (age 33.3 ± 10 years; F: 5, M: 7) were en-
rolled into these studies. The severity of the psoriasis 
skin lesions was assessed according to the Psoriasis 
Area Severity Index score (PASI) (minimum point 
0, maximum point 72) and ranged from 9.6 to 34.6 
(mean ± S.D., 21.4 ± 8.1). The AD patients were diag-
nosed according to the criteria defined by Hanifin 
and Rajka (1993). Disease severity in AD was mea-
sured according to the Severity Scoring of Atopic 
Dermatitis (SCORAD) (minimum point 0, maximum 
point 100) and ranged from 12 to 82 (mean ± S.D., 
42.1 ± 19.3). Patients on UV therapy, systemic or lo-
cal corticosteroid treatment, or with viral infections 
were excluded from the studies. Healthy control 
subjects had no clinical signs of dermatologic or al-
lergic diseases. 
Flow cytometry analysis. Human blood was 
collected and peripheral blood mononuclear cells 
(PBMC) were harvested following LSM1077 (PAA 
Laboratories) gradient separation. Cells were blocked 
with 50–80% autologous plasma and then stained for 
flow cytometry using mAbs to CD56, CD16 and CD3 
(reagents from BD Pharmingen eBioscience, Beck-
man Coulter and Dako). Stained cells were analyzed 
on an LSRII flow cytometer (Becton Dickinson). 
NK cell chemotaxis assay. Blood was collect-
ed from psoriasis and AD patients as well as normal 
individuals, and PBMC were harvested as described 
above. The chemotaxis assay was performed using 
5-µm pore Transwell inserts. PBMC (0.4–0.5 × 106) 
in 100 µl were added to the top wells, and various 
chemoattractants were added to the bottom wells in 
a 600 µl volume. Migration was assayed for 2 h at 
37oC, then the inserts were removed, and the cells 
that had migrated through the filter to the lower 
chamber were harvested, stained with anti-CD16-
FITC, anti-CD56PE, and analyzed by flow cytom-
etry. The number of gated NK cell subsets defined 
as CD56hi CD16- or CD56low CD16+ subsets counted 
in 60 s was used as the migration output. 
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Immunocytochemistry. Frozen 8-µm sec-
tions were prepared from skin biopsies. Sections 
were fixed in acetone, blocked with mouse IgG and 
stained with the following directly conjugated an-
tibodies; APC-anti-CD3 (BD Pharmingen) and PE-
anti-CD56 (Biolegend) or PE-anti-BDCA2 (Miltenyi 
Biotech). 
Statistical analysis. For statistical evaluation, 
two-tailed Student’s t-test was performed. 
RESULTS
Psoriasis and atopic dermatitis (AD) represent 
chronically relapsing skin diseases with skin-infil-
trating leukocytes playing a crucial role in the ini-
tiation and maintenance of both disorders (Leung 
et al., 2004; Nestle et al., 2005). However, whereas 
autoimmune psoriasis is characterized by substan-
tial numbers of skin-infiltrating pDC that signifi-
cantly contribute to the pathogenesis of the disease 
(Nestle et al., 2005), few pDC are present in skin le-
sions of AD patients (Wollenberg et al., 2002). No-
tably, the percentage of circulating pDC is lower in 
psoriasis patients compared to healthy individuals, 
whereas a higher frequency of pDC is noted in AD 
patients, suggesting that pDC leaving the circula-
tion could account for the lower percentage of these 
cells among circulating leukocytes in patients suf-
fering from psoriasis (Skrzeczynska-Moncznik et al., 
2009). To examine whether NK cells follow a similar 
frequency pattern, we analyzed NK cell subsets de-
rived from the blood of psoriasis and AD patients as 
well as normal donors by flow cytometry. Two sub-
sets of circulating NK cells have been reported; CD-
56low CD16+ NK effector cells, and CD56hi CD16– NK 
cells, characterized by limited cytotoxic function but 
a pronounced immunoregulatory phenotype (Otta-
viani et al., 2006; Parolini et al., 2007). As shown in 
Fig. 1, similar percentages of CD56hi CD16– NK cells 
were found in normal individuals as well as psoria-
sis and AD patients. In contrast, the percentage of 
circulating CD56low CD16+ NK cells was lower in 
AD, but not psoriasis patients, compared to healthy 
individuals. The reduced frequency of NK cells in 
patients suffering from AD is in agreement with a 
previous report (Katsuta et al., 2006). Taken together, 
these data suggest that the recruitment of pDC and 
NK cell is regulated by different mechanisms. 
To assess functional migratory responses of 
NK cells, we performed in vitro transwell chemo-
taxis assays on freshly isolated PBMC from normal, 
psoriasis, and AD patients, and stained for NK cell 
subsets after migration. The migratory response of 
NK cells to CXCL12, CXCL10 and chemerin was an-
alyzed. All three chemoattractants have been shown 
before to support pDC migration to diseased skin 
(Vanbervliet et al., 2003; Albanesi et al., 2009; Skrze-
czynska-Moncznik et al., 2009). Whereas the homeo-
static chemokine CXCL12 and the inducible pro-in-
flammatory chemokine CXCL10 are present in both 
psoriatic and AD skin, active chemerin appears to 
be primarily associated with psoriasis (Albanesi et 
al., 2009; Skrzeczynska-Moncznik et al., 2009). In ad-
dition to pDC, NK cells have been reported to ex-
press CMKLR1 (Vermi et al., 2005; Zabel et al., 2005b; 
2006b; Parolini et al., 2007), suggesting that, simi-
larly to pDC, they might be recruited via chemerin 
activation in skin disorders. We first determined 
whether circulating NK cells derived from psoria-
sis patients migrated more efficiently to chemerin 
compared with normal controls. Of the two NK cell 
subsets, only the CD56low CD16+ NK cells migrated 
to chemerin (Fig. 2), in agreement with previous 
studies demonstrating selective expression of func-
tional CMKLR1 by CD56low CD16+ NK cells (Paro-
lini et al., 2007). However, there were no significant 
differences in CD56low CD16+ NK cell migration to 
chemerin among the patient groups (Fig. 2A). CD-
56low CD16+ NK cells from all groups also responded 
with similar migration efficiency to CXCL12 (Fig. 
2A). The CD56hi CD16– NK cell subset, although 
unresponsive to chemerin, migrated efficiently to 
CXCL12 (Fig. 2B). CXCL10 was a more potent chem-
oattractant for CD56hi CD16– NK cells than for CD-
56low CD16+ NK cells, perhaps reflecting preferential 
expression of CXCR3 on the CD16– subset (Ottaviani 
et al., 2006). A combination of CXCL12 and CXCL10 
Figure 1. Circulating NK cells are present at a lower fre-
quency in AD patients compared with psoriasis patients 
and normal donors.
PBMC were isolated from the blood of indicated donors 
and stained for NK cells using anti- CD56 and CD16 
mAbs. The cells were then analyzed by flow cytom-
etry. Data are shown as percentage of NK cell subsets 
among the cells falling in a lymphocyte light scatter gate 
(mean  ± S.D. for the indicated number of donors; normal 
n = 6; psoriasis n = 10; AD n = 8). Statistically significant dif-
ference between normal and AD NK cell levels is indicat-
ed by asterisk (*P < 0.05; Student’s t-test). 
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triggered the most robust chemotactic response in 
both NK cell subsets (Fig. 2). Taken together, these 
findings confirm a differential pattern of chemotac-
tic responses by NK cell subsets but indicate similar 
chemotactic properties of NK cell subsets among the 
donor groups. 
Previous immunohistochemical data sug-
gest that NK cells are recruited to psoriasis and AD 
skin (Buentke et al., 2002; Ottaviani et al., 2006). In 
agreement with those studies, we found NK cells 
(CD56+CD3– cells of lymphocyte morphology) in the 
dermis of lesional skin from psoriasis and AD pa-
tients (Fig. 3A). NK cells were present throughout 
the T cell-rich infiltrate in the dermis, although small 
clusters of NK cells essentially devoid of T cells 
were also observed in inflamed AD skin (Fig. 3A). 
The same skin biopsies failed to stain for pDC (not 
shown), suggesting different recruitment pathways 
for NK cells and pDC. Since infiltration of psoriat-
ic skin by pDC appears to be associated only with 
early phases of developing skin lesions (Albanesi et 
al., 2009), we also analyzed biopsies of pDC-infil-
trated psoriatic skin for NK cells. As demonstrated 
in Fig. 3B, pDC were found in the dermis and the 
dermal papillae, in the latter case without obvious 
co-localization of T cells. In contrast, NK cells were 
primarily associated with T cell infiltrates in the der-
mis. Moreover, the distribution of NK cells was sim-
ilar in pDC-positive and pDC-negative skin biopsies 
(Fig. 3A and B), suggesting that NK cell trafficking 
to psoriatic skin is not paralleled by pDC recruit-
ment. 
DISCUSSION
Psoriasis is one of the most common au-
toimmune disorders in humans and recent findings 
Figure 2. CD56low CD16+ blood NK cells from normal 
donors as well as psoriasis and AD patients respond to 
active chemerin. 
Total PBMC were tested in transwell chemotaxis, and the 
migrated cells were stained for CD56 and CD16 to define 
two circulating NK cell subsets, CD56low CD16+ (A) and 
CD56hi CD16– (B). The following chemoattractants were 
used as indicated: CXCL12 (10 nM), CXCL10 (115 nM) 
and chemerin/SspB (50 pM). Migration to chemotaxis me-
dium served as a negative control (Medium). NK cell sub-
set migration is displayed as the mean of six independent 
donors in each group  ± S.D. Statistically significant differ-
ences in the migration to the negative control (chemotaxis 
medium) vs. various chemoattractants in pairwise compar-
isons within patient groups was determined by Student’s 
t-test (P < 0.05) and indicated by *.
Figure 3. NK cell skin infiltration does not 
correlate with pDC influx.
Frozen sections of skin biopsies from indicated 
patients were stained to detect T cells (CD3+, 
blue), NK cells (CD56+, red; CD3–) or pDC 
(BDCA2+, red). Autofluorescent components of 
extracellular matrix are shown in green. The 
slides were examined by fluorescence micros-
copy. Original magnification: ×10. Dotted lines 
in B indicate location of epidermis. Arrows in-
dicate NK cells (upper panel and lower panel, 
left) and pDC (lower panel, right). Data shown 
in B represent serial sections. Data are rep-
resentative of three different donors in each 
staining combination.
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strongly implicate activated pDC in this pathologic 
condition (Nestle et al., 2005; Lande et al., 2007). In-
terestingly, both pDC and NK cells constitute the in-
flammatory infiltrate in psoriasis, suggesting possible 
crosstalk between these cells in the initiation and/or 
maintenance of psoriatic inflammation. The mutual 
interaction of pDC with NK cells has been report-
ed to profoundly influence activation status of both 
types of cells, leading on one hand to the augmen-
tation of NK cell cytolytic activity by pDC, and on 
the other hand, to the induction of pDC maturation 
by activated NK cells (Gerosa et al., 2005). Therefore, 
reciprocal contact between pDC and NK cells would 
be predicted to be of important consequence for the 
development of psoriatic lesions and a better under-
standing of the rules that govern the pDC-NK rela-
tionship will help develop new approaches for the 
diagnosis and/or treatment of psoriasis. 
Since circulating pDC and NK cells both ex-
press CXCR3 and CMKLR1, we reasoned that their 
respective ligands, CXCL10 and chemerin, might 
contribute to either pDC or NK cell influx to pso-
riatic skin, enabling local interactions between these 
cells in psoriatic plaques. Chemerin appears to coop-
erate with CXCL10 in directing pDC to skin in pso-
riasis (Skrzeczynska-Moncznik et al., 2009). Notably, 
while CD56hi CD16– NK cell infiltrates have been 
reported in psoriatic skin, CD16+ NK cells have not 
been detected (Ottaviani et al., 2006). Since circulat-
ing CD56hi CD16– NK cells from psoriasis patients 
do not migrate to chemerin (while CD16+ NK cells 
do) (Fig. 2), this implies that chemerin-independent 
mechanisms likely guide the recruitment of CD56hi 
CD16– NK cells to psoriatic skin, and that the regu-
lation of CD16+ NK cell recruitment is more com-
plex than simply by chemerin: CMKLR1 interac-
tions. Other chemokines might provide alternative 
or additional signals to regulate NK cell infiltration 
of diseased skin, including CCL5, CCL4 or CXCL8 
(Leung et al., 2004; Ottaviani et al., 2006; Parolini et 
al., 2007). 
Chemerin has been shown to play a role in 
the co-localization of NK cells and pDC in oral li-
chen planus lesions (Parolini et al., 2007), suggesting 
that the accumulation of both NK cells and pDC ob-
served in other skin diseases might depend on this 
chemoattractant. However, the results of this work 
together with previous reports (Parolini et al., 2007; 
Albanesi et al., 2009; Skrzeczynska-Moncznik et al., 
2009) suggest that, despite being chemerin-respon-
sive, pDC and NK cells follow distinct trafficking 
patterns in skin disorders. First, the differences in 
the frequency of circulating pDC and NK do not 
similarly reflect disease-associated variations in pDC 
and NK cell migration to local sites. Furthermore, 
NK cells infiltrate either psoriasis or AD skin, even 
though AD skin appears to be largely chemerin-
negative (Skrzeczynska-Moncznik et al., 2009) and 
pDC are thought to be generally absent in AD skin 
lesions (Wollenberg et al., 2002). Moreover, psoriatic 
skin infiltration by NK cells does not correlate with 
pDC recruitment into skin, since NK cells mixed 
with T cells can be found in psoriatic skin despite 
the absence of pDC. Finally, pDC-positive biopsies 
of lesional psoriatic plaques that are likely to contain 
chemotactively active chemerin (Albanesi et al., 2009; 
Skrzeczynska-Moncznik et al., 2009) do not show ob-
vious co-localization of NK cells and pDC. 
Taken together these data suggest at least par-
tially distinctive homing properties of pDC and NK 
cells to diseased skin and implicate other chemoat-
tractants that may play additive effects in recruiting 
these leukocytes to inflamed skin. 
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